BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17287625)

  • 41. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
    Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
    Szlam F; Taketomi T; Sheppard CA; Kempton CL; Levy JH; Tanaka KA
    Anesth Analg; 2008 Mar; 106(3):719-24, table of contents. PubMed ID: 18292408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of an acidic environment on coagulation dynamics.
    Gissel M; Brummel-Ziedins KE; Butenas S; Pusateri AE; Mann KG; Orfeo T
    J Thromb Haemost; 2016 Oct; 14(10):2001-2010. PubMed ID: 27431334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enzymological aspects of blood coagulation.
    Kisiel W; Fujikawa K
    Behring Inst Mitt; 1983 Aug; (73):29-42. PubMed ID: 6689603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contact activation of coagulation depends on the maximal lipophilic trigger concentration.
    Stief TW
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):296-8. PubMed ID: 22473046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of factor XI in thrombin generation induced by low concentrations of tissue factor.
    Keularts IM; Zivelin A; Seligsohn U; Hemker HC; Béguin S
    Thromb Haemost; 2001 Jun; 85(6):1060-5. PubMed ID: 11434685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contact between a polymer and whole blood: sequence of events leading to thrombin generation.
    Hong J; Larsson A; Ekdahl KN; Elgue G; Larsson R; Nilsson B
    J Lab Clin Med; 2001 Aug; 138(2):139-45. PubMed ID: 11477381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombin generation in patients after acute deep-vein thrombosis.
    ten Cate-Hoek AJ; Dielis AW; Spronk HM; van Oerle R; Hamulyák K; Prins MH; ten Cate H
    Thromb Haemost; 2008 Aug; 100(2):240-5. PubMed ID: 18690343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human monocytes have prothrombin cleaving activity.
    Hogg N
    Clin Exp Immunol; 1983 Sep; 53(3):725-30. PubMed ID: 6352100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The measurement and application of thrombin generation.
    Baglin T
    Br J Haematol; 2005 Sep; 130(5):653-61. PubMed ID: 16115120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombin generation tests.
    Castoldi E; Rosing J
    Thromb Res; 2011 Feb; 127 Suppl 3():S21-5. PubMed ID: 21262433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombin generation in vascular tissue.
    Pathak A; Zhao R; Monroe DM; Roberts HR; Sheridan BC; Selzman CH; Stouffer GA
    J Thromb Haemost; 2006 Jan; 4(1):60-7. PubMed ID: 16409451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
    Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
    Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammo-coagulatory response, extrinsic pathway thrombin generation and a new theory of activated clotting time interpretation.
    Gil W
    Perfusion; 2001 Jan; 16(1):27-35. PubMed ID: 11192304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of gamma irradiation with 30 Gy on the coagulation system in leukoreduced fresh-frozen plasma.
    Weisbach V; Strobel J; Hahn B; Rödel F; Lotter M; Zingsem J; Ringwald J; Eckstein R
    Transfusion; 2007 Sep; 47(9):1658-65. PubMed ID: 17725731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Heparin and antiheparin in young children. 1. Report: development of a method for determining heparin and antiheparin in the antithrombin-thrombin system].
    Domula M; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):808-23. PubMed ID: 6188669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monitoring hypocoagulant conditions in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma.
    Nieuwenhuys CM; Feijge MA; Béguin S; Heemskerk JW
    Thromb Haemost; 2000 Dec; 84(6):1045-51. PubMed ID: 11154112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.